Facebook
Twitter
LinkedIn
ForwardWebinar: Nutritional Considerations in the Era of GLP-1R Agonists
GLP-1 receptor agonists (GLP-1RAs) have been used in medicine for several decades and now new, long-acting versions of these medications are approved for the treatment of overweight and obesity. Clinicians have seen a rapid increase in use of these medications, which has led to a resurgence in patients’ interest in weight loss. Clinical trial data suggests that GLP-1R agonists are highly effective, with efficacy rates approaching that of bariatric surgery. However, with significant weight loss comes an increased need for nutritional guidance to help patients maintain quality of life and avoid nutritional deficiencies commonly observed during caloric restriction.
Join Jonathan Clinthorne, PhD, and Kristin Kirkpatrick, MS, RD, on Thursday, August 15, 2024, from 2-3 p.m. ET, for a complimentary webinar that will review clinical research on GLP-1 receptor agonists, discuss individualized nutritional approaches that may help different patients, and provide a deeper understanding of how anti-obesity medications (AOM) may shape the health and nutrition landscape of the future.
Learning Objectives
After completing this activity, nutrition professionals will better be able to:
- Discuss the different GLP-1 receptor agonists and understand their use as anti-obesity medications.
- Describe how these medications compare to other weight loss interventions and how previous clinical concepts are still applicable to patient populations struggling with overweight and obesity.
- Review practical aspects of personalizing nutrition advice for different patients using GLP-1 receptor agonists based on the available scientific evidence.
Additional Information
Jon Clinthorne, PhD, received his doctorate in Human Nutrition from Michigan State University for his work focusing on the intersection of diet, metabolism, and immune function. His research has been published in several top-tier journals including the Journal of Nutrition, Frontiers in Nutrition, and the Journal of Immunology. As the Senior Director of Nutrition at Simply Good Foods, Jon is involved in new product research and development, creating continuing education courses, and establishing relationships with health care professionals.
Kristin Kirkpatrick, MS, RD, is a registered dietitian with over 20 years of experience in integrative nutrition. Kristin has spent her entire career as a dietitian at the Cleveland Clinic Department of Wellness and Preventive Medicine. She’s a best-selling author of two books - “Skinny Liver” and “Regenerative Health” - an experienced presenter, and an award-winning dietitian. Kristin serves as a contributing writer for TODAY.com, Eating Well Magazine, Costco Connection, and Cleveland Clinic “Health Essentials.”
Disclosures:
Jonathan Clinthorne, PhD, has the following relevant disclosure to report: he is an employee of Simply Good Foods USA, Inc.
Kristin Kirkpatrick, MS, RD, has the following relevant disclosures to report: she is a consultant to Quest Nutrition, the Practitioner on Record for Evitatmins.com, a health coach for Prolon, and a consultant for Jetson Health.
Funding from non-CPE revenue for CPE planning, development, review, and/or presentation has been provided by Simply Good Foods USA, Inc.
Nutritional Considerations in the Era of GLP-1R Agonists awards 1.0 CPEU in accordance with the Commission on Dietetic Registration's CPEU Prior Approval Program. The responsible provider for this activity is Simply Good Foods USA, Inc.
Available Credit
- 1.00 CDR
Price
Required Hardware/software
Ensure your browser's cookies are enabled in order for the webinar software to function properly. Please add "ce@gvpub.com" to your email provider's safe list. Otherwise, login instructions for this event may be caught in your spam/junk folder.